Nanosonics Limited Issues New Securities Under Employee Incentive Scheme
Nanosonics Limited (AU:NAN) has announced the issuance of 289,148 ordinary fully paid securities under an employee incentive scheme, which will be quoted on the ASX. This initiative reflects the company's commitment to employee retention and market strength. The latest analyst rating for AU:NAN is a Buy with a price target of A$4.50. Nanosonics specializes in infection prevention solutions in the healthcare sector, particularly in ultrasound probe disinfection, with a current market cap of A$1.25B.
Nanosonics Limited ( (AU:NAN) ) has provided an update.
Nanosonics Limited has announced the issuance of 289,148 ordinary fully paid securities, which will be quoted on the Australian Securities Exchange (ASX). This move is part of an employee incentive scheme, indicating the company’s commitment to rewarding and retaining its workforce, potentially strengthening its market position and operational capabilities.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$4.50 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the healthcare industry, specializing in infection prevention solutions. The company is known for its innovative products designed to reduce the risk of infections in medical settings, focusing on ultrasound probe disinfection.
Average Trading Volume: 776,916
Technical Sentiment Signal: Buy
Current Market Cap: A$1.25B
Find detailed analytics on NAN stock on TipRanks’ Stock Analysis page.
